Phlebotomy Tubes Market 2018 Global Analysis, Industry Size, Share Leaders, Current Status by Major Key vendors and Trends by Forecast to 2026

The procedure by which an incision is made in a vein is known as phlebotomy. The process is known as a venipuncture. Phlebotomist is a person who executes phlebotomy. However, doctors, medical laboratory scientists, and nurses often perform phlebotomy procedures as well. Phlebotomy is performed for various reasons such as medical testing, donations, research, and transfusions. The responsibility of a phlebotomist include identifying the patient, understanding the tests suggested by the physician, accurately identifying the site in the patient body, drawing blood into the proper tubes containing proper additives, correctly elucidating the process to the patients, preparing patients, working on the desired structures of asepsis, following customary and universal safety measures, reinstating hemostasis of the site, educate patients on post-prick care, fasten tubes with printed labels by electronic means, and making sure that the specimen is not contaminated before it reaches the laboratory.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/144

Technological advancement and growing prevalence of phlebotomy in Asia Pacific will make phlebotomy tubes market potential high

According to WHO report, almost half the world’s population is at a risk of malaria, a disease that is diagnosed only through blood test which requires phlebotomy tubes. Advancement in science and technology has led the laboratories and diagnostic centers to opt for better machineries. However, the need for phlebotomy tubes is constant. Advanced machineries have propelled the demand for tests, thereby augmenting the demand for phlebotomy tubes. Moreover, medical practitioners are relying on blood tests of patients to avoid wrong treatment. Patients are increasingly being advised to perform regular blood tests for fatal diseases which do not show any symptoms until later, such as cancer and HIV/AIDS. This will fuel the overall phlebotomy tubes market.

Some of the major competitors operating in the market are Ajosha BioTeklik Pvt. Ltd., Medical Expo, CML Biotech Pvt. Ltd., Gosselin, New MicroMed International Pvt. Ltd., Advacare Pharma, Greiner BioOne, and FL Medical.

Middle Ear Implants Market Service Offered, Companies Mentioned, Service Provider, Business Model, Latest Application and Forecast 2026

Middle Ear Implants Market Overview

Middle implant ear is a small device inserted into the middle ear and coupled to ossicles. Middle ear implants are devices designed for those who suffer mild- moderate mix or sensorineural hearing loss and conductive hearing loss. Middle ear implant is an advanced technology for the conventional use of hearing aid. A middle ear implant is recommended for people suffering from earmould allergies, skin problems, ear infections, collapsed or closed ear canals, etc. It can also serve as an alternative to bone anchored hearing aid. The difference between middle ear implant and other hearing aid is that it do not require a speaker. Middle ear implant transmits sound to the middle ear through the microphone placed behind the ear. The microphone converts sound to mechanical vibration and is sent to floating mass transducer placed in the middle ear.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/137

Increasing Government Support in Developed Regions to Address Growing Prevalence of Hearing Loss to Augment Growth of Middle Ear Implants Market

Increasing concerns related to hearing loss is expected to drive growth of the market in middle ear implants. As per a WHO report, as of 2012, around 360 million people worldwide suffered from hearing loss, which accounts for around 5.3% of the world population. Out of the total hearing loss patient population, 91% were adults with children accounting for the rest. The increasing cases of hearing loss due to exposure to loud noise, trauma, viral infections, increasing geriatric population, and rising incidence of malformation of inner ear are expected to drive growth of the overall middle ear implants industry.  Increasing government regulations for early screening, diagnosis and treatment of hearing problems further augments growth of the middle ear implant market. In the U.S., Medicaid regulates one such program called the Early and Periodic Screening, Diagnosis and Treatment (EPSDT) Program.

Major middle ear implant products in the market:        

Esteem Hearing Implant (Envoy Medical), MAXUM Hearing Implant (Ototronix), cochlear implant (CI) system (MED-EL Corporation), Ossicular (middle ear) implant (Medtronic)

Major Players in the middle ear implants market

Major players involved in the middle ear implants market include Envoy Medical, Ototronix, MED-EL Corporation, Medtronic, CENTILLION and Cochlear.

Orthopedic Trauma Devices Market 2018 by Size, Share, Products, Alliances, Recent Contract and Financial Analysis, Forecast to 2026

Orthopedic trauma devices are commonly used in fractures of skeletal system. These devices include internal fixator, which are placed surgically at the location of fracture, and includes screw and plates system, nails, implants, and cables and wires. Plates comes with different number of holes (2 holes, 6 holes) depending on the severity of trauma, also it comes with standard, locking, and hybrid version. Intramedullary nails are to be used at different surgical sites such forearm, humerus, femur, tibia, and ankle. Screw comes either as intramedullary or cannulated, which are used at hips and other location. External fixator system are used to support the leg or hand for external support. It comes with different designs such as unilateral, circular, or hybrid.

Rising number of orthopedic trauma cases is expected to drive growth of the orthopedic trauma devices market

Trauma, which causes skeletal injury is associated with number of causes such as road accident and fall injury. Increasing number of trauma associated with road accidents and other causes is expected to propel growth of the orthopedic trauma devices market. According to Global Burden of Disease report published by Lancet in 2015, road injuries is one of leading cause amongst 20 causes of the disease burden worldwide. Rising number of fall injuries is also expected to boost orthopedic trauma devices market, as often fall injury causes dislocation and breakage of bones, which may require surgical procedure. According to World Health Organization (WHO) factsheet in 2018, each year there are around 37.3 million falls, which requires medical attention whereas estimated 646,000 individuals die from falls globally every year. Rising geriatric population would also aid in growth of the orthopedic trauma devices market, as people in this age group are more prone to bone fractures, due to fall injury and other orthopedic complications. According to a WHO factsheet, 2018, adults older than 65 years of age suffer from the greatest number of fatal falls. According to United Nation report titled World Population Prospect -the 2017 revision, global population of people aged over 60 years would rise from 962 million to 1.3 billion by 2030, which in turn could be a leading factor for increasing demand for orthopedic trauma device, over the forecast period.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/130

Key players present in orthopedic trauma devices market are Stryker Corporation, Zimmer Holding Inc., Smith & Nephew, Biomet, Inc, DePuy Synthes (a Johnson & Johnson Company). Other prominent players are Braun Melsungen AG, Arthrax, Inc., Medtronic Inc., Integra LifeSciences Corporation, Orthofix International, NuVasive, and Conmed Corporation.

Breast Biopsy Devices Market CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast to 2026

A breast biopsy is the removal of a sample of breast tissue or cells that is to be tested for breast cancer or any others breast related disorders. Breast biopsy is mainly preferred to detect breast cancer. The medic may recommend a biopsy when the female patient has an uncharacteristic lumps in the breast. A doctor may also recommend a breast biopsy when the patient has an abnormal change in the nipple such as any cellulite, congealing, scaling, or crusting of the skin. If a diagnostic test with the use of mammogram, ultrasound or MRI unveils an area or a region in the breast that appears with a lump in the breast, or in a nearby lymph node, a biopsy may be recommended.

Vacuum-assisted breast biopsy is the dominating segment in the global breast biopsy devices market

Prevalence of breast cancer or suspicious lesions that might need a biopsy increases with age. Vacuum-assisted breast biopsy (VABB) are widely used owing to their low price and quick response time as compared to other diagnostic devices such as ultrasound, x-ray, computed tomography (CT), or magnetic resonance imaging. For instance, according to Hologic, C.R. Bard and Mammotome Company, VABB accounts for 90% of its revenue in the breast biopsy devices. Some of the other factors driving the market for breast biopsy devices market are increasing level of awareness. The American Cancer Society, Inc, advises men and women to attend self-awareness exams conducted through the year, which helps individual to detect any change in their breast which would be further diagnosed by the physician. Higher incidence of breast cancer is also attributed to increasing exposure to toxic chemicals. According to Occupational Safety and Health Agency (OSHA) and the National Institute of Occupational Safety and Health (NIOSH), in the U.S., around 50,000 workers die each year as a result of past exposure to hazardous agents. However, high procedure cost and side effects such as bleeding and infections post-procedure are some of the factors restraining market growth for breast biopsy devices.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/123

Hologic is one of the major company for breast biopsy devices market

Key players operating the breast biopsy devices market include Biomed Diagnostics, Inc., Bard Peripheral Vascular Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., Intact Medical, Mammotome, OncoCyte Corporation and Laboratory Corporation of America Holdings (Labcorp), among others. Major companies in the market are constantly working towards introducing innovative products and lowering production costs in order to enhance profitability. For instance, in the recent times C. R. Bard expanded the use of its devices by offering reusable biopsy handles for free when disposable biopsy needles are purchased.

Cell Culture Market Worldwide Overview By Industry, Growth Factors and Leading Players

The technique of growing cells outside the human body itself is a significant advancement in scientific research. Cell culture technique has been around since mid-20th century and the field is continuously expanding into various areas of pharmaceutical research and development such as cancer and immunotherapy. Endeavor to improve the drug bioavailability and therapeutic efficacy has led to better research outcomes in cancer and health screening techniques. The ability to develop continuous cell lines has enabled mass production of desired organ cells for research and treatment benefits. Cell culture offers an excellent model system for studying the normal physiology and biochemistry, drug effects and drug screening. Being an exploratory research field, use of reagents, instruments and other consumables is very critical to support its advancements.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/116

High Investment in research and development by biotechnological companies

Players in the global cell culture market are making major investments in R&D to introduce advanced products used in the cell culture process owing to rise in number of application and better return on investment. Furthermore, companies are inclined towards novel product development. For instance, Biovest International, in 2009, has developed a product named AutovaxID-C, which is expected to reshape the biologic production made in the industry. The product favors the automated cell growth by replacing conventional cell growth chambers that use to acquire a large space in the laboratory. Various other factors such as increasing prevalence of chronic diseases, high importance of tissue or organ replacement with cell culture process, and increasing demand for antibody production are in turn projected to fuel cell culture market growth. Also, rise in prevalence of age-related macular degeneration is expected to underpin the cell culture market growth. Eye conditions such as diabetic retinopathy in tune with rise in number of diabetic patients globally in turn creates a conducive environment for growth of the cell culture market. AMD ranks third with a prevalence of around 8.7% globally in 2015, according to W.H.O.

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., GE Healthcare, Corning, Inc., Sigma – Aldrich Corporation, VWR International, LLC, Merck KGAA, Becton, Dickinson and Company, Eppendorf AG, Sartorius AG and Lonza Group AG

CAR T Cell Therapy Market trends, drivers, restraints, and opportunities 2018-2026

CAR-T cell therapy is a novel immunotherapy that helps to treat various types of cancers. CAR-T cells are genetically engineered cell receptors that are attached to the T-cells of the cancer patients and infused through the blood stream that activates immune system to kill the cancer causing cells in the body. The T-cells injected into the patient’s body aids in reducing the risk of recurrence of tumor and thus, acts as a cure treatment for patients suffering with blood cancer. The CAR-T cell therapy is a solution to overcome the disease progression, identify the cancer causing cells, and kill them using body’s own immune system and defense mechanism.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/102

Market players are engaged in developing and launching innovative products and adopt merger and acquisition strategies to retain position in the global CAR-T cell therapy market

Key players in the market are engaged in extensive research and development to launch new targeted cell therapies in the market. For instance, the University of Texas MD Anderson Cancer Center, Houston is conducting phase 1 clinical trial studies of central memory–derived CD19 CAR T–cell therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma. Moreover, key players are focusing on strategic merger and acquisition to enhance their share in the global CAR-T cell therapy market. For instance, in April 2018, Pfizer, Inc. signed a deal with Allogene, to develop an investigational CAR-T cell therapy for treating cancer.

Key players operating in the global CAR-T cell therapy market include Novartis International AG, Kite Pharma, Inc. (Gilead Sciences, Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio, Inc. (Celgene Corporation), Sorrento Therapeutics Inc., Mustang Bio, Inc., Aurora Biopharma Inc., Legend Biotech (Genscript Biotech Corporation), Pfizer, Inc., CARsgen Therapeutics, Ltd., and others.

Companion Diagnostics Market Opportunity Analysis, Vendor Landscape, Growth, Developments & Forecast 2018-2026

Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/109

Low cost and clinical benefits of companion diagnostics is expected to drive growth of the market

The ecosystem of pharmaceuticals industry is one of the major factors driving growth of the companion diagnostics market. The providers of healthcare products and services, and patients who utilize these products and services is expected to be benefitted by a collaborative approach. The innovation of CDx helped drug developers in reducing the development costs, developing highly effective therapeutic products, and improving the time to market by identifying the effectiveness of a drug against particular biomarkers. Moreover, better treatment outcomes and lower morbidity risk are benefits offered to the patients. Also, accurate diagnosis and determination of targeted cancer therapy has become much easier due to advanced technologies such as PCR, immunohistochemistry, and gene sequencing.

Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare

Constipation Treatment Market Breakdown, Development and New Market Opportunities & Forecasts

Constipation Treatment Market Overview

Constipation is a disorder that causes issues related to clearing of the bowels and usually leads to hardened feces. It is especially prevalent among the elderly and women. Common symptoms of constipation include lumpy or hard stools, lower abdominal discomfort, straining to have bowel movements, feeling of blockage in rectum that prevents bowel movements, and infrequent bowel movements. Factor that can lead to constipation are aging, dehydration, little or no physical activity, diet low in fiber, and mental conditions such as depression or eating disorder. Constipation treatment starts with lifestyle and change in diet to increase the speed at which stool moves through intestines. If it doesn’t help then the physician recommend medications or surgery. Lifestyle and diet change includes increase in fiber intake and physical activities such as exercise to increase intestinal muscle activities.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/95

High prevalence rate in North America drive growth of the Constipation Treatment Market

High prevalence rate in North America due to increasing adoption of unhealthy lifestyle characterized by growing consumption of fast food is leading to increasing obesity and other related health issues. This inadvertently leads to high incidence rate of constipation in the region.

According to the American Society of Interventional Pain Physicians, the U.S. accounts for around 80% of the global opioids consumption. According to an article published in the American Gastroenterological Association in May 2015, chronic constipation affects one in six people in the U.S. and is the third-leading symptom prompting outpatient clinic visits in the country. It is especially prevalent in overweight women. High acuity information system, high disposable income level, and rampant adoption of unhealthy lifestyle in Europe makes it a potential high growth market. Asia Pacific too is expected to be a lucrative market for constipation treatment, mainly due to increasing westernization characterized by rising adoption of non-nutritious fast food in the region.

Global players engaged in the constipation treatment market

The major players operating in constipation treatment market include AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Valeant Pharmaceuticals International, Inc., C.B. Fleet Company Inc., Daewoong Co. Ltd., Sucampo Pharmaceuticals Inc., Cosmo Pharmaceuticals, Synergy Pharmaceuticals Inc. Boehringer Ingelheim GmbH, and Ironwood Pharmaceuticals.

Geriatric Care Services Market Global and Regional Analysis by Top Players, Product Segments, Key Regions and Applications 2026

Elderly population suffering from chronic conditions require frequent physician visits, health monitoring and assistance in performing daily activities. Geriatric care service providers offer end-to-end solutions to the elderly population in need of assistance in order to ease their living. Coordinating with the doctor, assessing any medical or nutritional need, assistance in medical and financial planning, home nursing services, and devising complete medical care plans are some of the services offered by various geriatric care service market players.

Growing demand for continuing care in the global geriatric care services market

Geriatric care centers provide services include home healthcare, assisted living facilities, adult day care services, continuing care recruitment, and skilled nursing facilities. Skilled nursing facilities and home healthcare are the major revenue contributors for providers, owing to involvement of more time and workforce in these service types. However, demand for continuing care is increasing rapidly. Elderly population is highly prone to injuries, and therefore require continual care. Also, increasing women labor workforce participation has led to increase in demand for continuing care. The continuing care service type segment in the global geriatric care services market is projected to develop at a CAGR of 4.6% during the forecast period (2016-2024).

Key companies covered as a part of this study include Brookdale Senior living, Sunrise Senior Living Inc., Senior Care Centers of America, Kindred Healthcare Inc., GGNSC Holdings, LLC, Extendicare, Inc., Home Instead Senior Care Inc., Gentiva Health Services Inc., and Genesis Healthcare Corp.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/88

Breast Pumps Market by New Market Opportunities, Production Cost Analysis, Market Development and Market Dynamics Forces

Breast pump devices enable women to express breast milk and store it for later use. These are especially useful for working mothers nursing a newborn. Breast pumps gaining eligibility for reimbursement under the Affordable Care Act is a key trend promoting its adoption in the U.S. Working mothers usually prefer automatic electronic breast pumps. These automatic breast pumps have adjustable suction level and variable cycling time, which offers enhanced comfort to the use. Double pumps help reduce pumping time as they drain both breasts simultaneously and more effectively.

Growing number of women in the workforce providing growth impetus

According to the U.S. Department of Labor (DOL), around 57% of women were part of the U.S. workforce in 2015. Furthermore, the DOL projects that by 2024, women in the age group of 25 to 34 years would constitute the major share of employed women in the U.S. On the contrary, emerging economies such as India have witnessed a decline in the female workforce from 35% in 1990 to 27% in 2014 (as per the World Bank Statistics). This is mainly attributed to cultural and societal factors and dearth of suitable jobs opportunities close to place of residence. However, liberalized thinking women empowerment programs are expected to change the scenario and drive growth in the number of women enlisted with the workforce in the country during the forecast period. Countries such as Bangladesh and Sri Lanka have reported a significant increase in participation of women in the workforce as per the 2015 World Bank data.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/81

Key companies covered as a part of this study include Medela AG, Ameda Breastfeeding Solutions, Philips AVENT, Lansinoh Laboratories, Inc., Hygeia Medical Group, Whittlestone, Inc., Bailey Medical, Energizer Personal Care, LLC (Playtex Baby), Jarden Corporation, Handi-Craft Company, and Mayborn Group Limited.